Atlas Trials

Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)

Clinical trial NCT02952586 · TERMINATED

Trial details

NCT number
NCT02952586
Sponsor
Pfizer
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Squamous Cell Carcinoma of the Head and Neck
Start date
2016-11-28
Primary completion
2019-12-23
Enrollment
697

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.